Skip to content
Reipet – Lifestyle
Author:
HotSpot Therapeutics
HotSpot Therapeutics Appoints Niti Goel, M.D., as Chief Medical Officer
August 18, 2026
HotSpot Therapeutics Presents Preclinical Data from Small Molecule IRF5 Inhibitor Program at EULAR 2026
June 4, 2026
HotSpot Therapeutics to Present Preclinical Data from Small Molecule IRF5 Inhibitor Program at EULAR 2026
May 20, 2026